Hematologic Malignancy

Systemic Mastocytosis

HematologicNon-malignant9 active trials2 approved drugs4 evidence items

NCIt: C43284
NCIt: C9235
OncoTree: SM
DOID: 349
UMLS CUI: C0221013
MeSH: D034721

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (3)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–3 of 3 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
· N Engl J Med · 2016 · PMID 27355533 · validated civic_curation pubmed
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.
· Leukemia · 2016 · PMID 26464169 · validated civic_curation pubmed
Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis.
· Leuk Res · 2009 · PMID 19193436 · validated civic_curation pubmed